The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation under the model for end-stage liver disease (MELD) allocation system is still being debated. We analyzed the impact of a MELD adjustment for HCC, which consisted of the addition of an extra scor
Do Laparoscopy and Intraoperative Ultrasound Have a Role in the Assessment of Patients With End-Stage Liver Disease and Hepatocellular Carcinoma for Liver Transplantation?
β Scribed by M.S. Reddy; L. Smith; B.C. Jaques; K. Agarwal; M. Hudson; D. Talbot; D.M. Manas
- Book ID
- 116933283
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 51 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo
In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors o